In addition, whole exome-sequencing (WES) revealed a novel activating EGFR mutation-I645L, mediating JQ1 resistance by activating MAPK pathway and stabilizing MYC protein in HCC cells. The gene discussed is EGFR; the disease is hepatocellular carcinoma.